AMR and the Microbiome PACCARB Day 2 Part 2
Sep 23, 2026
The 28th public meeting of the PACCARB brings together leading scientists, clinicians, and policymakers to explore how human, animal, and environmental microbiomes influence the emergence, spread, and mitigation of resistant pathogens
---
U.S. Department of Health and Human Services (HHS)
http://www.hhs.gov
HHS Privacy Policy
AI GeneratedMay contain errors
Video Summary
AI GeneratedThis presentation explores microbiome-targeted therapies, specifically Fecal Microbiota Transplantation (FMT) and bacteriophage therapy, as alternatives to antibiotics to combat antimicrobial resistance (AMR). It covers clinical applications in humans and animals, the development of AI-driven precision platforms, and the systemic regulatory and financial barriers to patient access.